For the quarter ending 2026-03-31, CPHI has $45,143,790 in assets. $8,119,600 in debts. $168,474 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 168,474 | 345,112 | 267,625 | 625,032 |
| Bankers acceptances | - | - | 26,697 | 0 |
| Trade accounts receivable, less allowance for credit losses of 9,434 and 13,023 | 196,262 | 241,412 | 224,638 | 268,793 |
| Other receivables, less allowance for credit losses of 33,563 and 32,153, respectively | 61,657 | 49,261 | 61,275 | 48,361 |
| Advances to suppliers | 4,382 | 6,831 | 23,883 | 4,967 |
| Inventories | 1,498,501 | 1,621,423 | 1,649,682 | 1,678,769 |
| Prepaid expenses | 74,279 | 82,368 | 75,627 | 74,869 |
| Total current assets | 2,003,555 | 2,346,407 | 2,329,427 | 2,700,791 |
| Property, plant and equipment gross | 38,466,370 | 37,881,815 | 37,472,621 | - |
| Less accumulated depreciation | 34,162,377 | 33,489,851 | 32,970,142 | - |
| Property, plant and equipment, net | 4,303,993 | 4,391,964 | 4,502,479 | 4,625,907 |
| Right-of-use assets | 161,875 | 181,828 | 197,851 | 0 |
| Gross carrying amount | 45,504,300 | - | 14,288,424 | - |
| Accumulated amortization | 7,174,347 | - | 5,840,485 | - |
| Net carrying amount | 38,329,953 | 23,743,419 | 8,447,939 | - |
| Intangible assets in process | 344,414 | 335,846 | 327,097 | - |
| Intangible assets, net | 38,674,367 | 24,079,265 | 8,775,036 | 6,439,862 |
| Total assets | 45,143,790 | 30,999,464 | 15,804,793 | 13,766,560 |
| Trade accounts payable | 837,108 | 891,083 | 588,739 | 530,729 |
| Accrued expenses | 311,336 | 350,643 | 170,426 | 191,293 |
| Other payables | 2,591,141 | 2,563,067 | 2,303,183 | 2,344,882 |
| Contract liabilities | 61,746 | 111,580 | 120,912 | 77,683 |
| Borrowings from related parties | 1,466,145 | 1,435,136 | 1,413,340 | 1,407,607 |
| Lease liabilities | 71,386 | 71,628 | 70,326 | - |
| Current portion of lines of credit | 1,928,816 | 1,977,222 | 1,955,880 | 698,461 |
| Total current liabilities | 7,267,678 | 7,400,359 | 6,622,806 | 5,250,655 |
| Lines of credit, net of current portion | - | - | - | 1,319,915 |
| Lease liabilities, net of current portion | 92,294 | 111,548 | 128,257 | - |
| Deferred tax liability | 759,628 | 747,805 | 739,733 | 734,246 |
| Total liabilities | 8,119,600 | 8,259,712 | 7,490,796 | 7,304,816 |
| Common stock, 0.001 par value 500,000,000 shares authorized 40,522,002 shares and 15,522,002 shares issued and outstanding, respectively | 40,522 | 15,522 | 5,022 | 3,262 |
| Additional paid-in capital | 73,504,819 | 58,535,819 | 43,076,319 | 40,631,679 |
| Securities purchase agreement receivable | 180,000 | 180,000 | 180,000 | 180,000 |
| Accumulated deficit | -48,357,383 | -47,214,235 | -45,992,100 | -45,340,618 |
| Accumulated other comprehensive income | 12,016,232 | 11,582,646 | 11,404,756 | 11,347,421 |
| Total stockholders equity | 37,024,190 | 22,739,752 | 8,313,997 | 6,461,744 |
| Total liabilities and stockholders equity | 45,143,790 | 30,999,464 | 15,804,793 | 13,766,560 |
CHINA PHARMA HOLDINGS, INC. (CPHI)
CHINA PHARMA HOLDINGS, INC. (CPHI)